Navigation Links
Investigational drug tested for preventing muscle fiber death in muscular dystrophy
Date:3/16/2008

CINCINNATI An investigational antiviral drug currently undergoing human trials in Europe for treating Hepatitis C infections may have potential to reduce muscle cell damage in Duchenne and other forms of muscular dystrophy (MD). A research team led by Cincinnati Childrens Hospital Medical Center reported their results using three different mouse models of MD in a letter posted online March 16 by the journal Nature Medicine.

The investigational drug, Debio-025, is a known inhibitor of the protein cyclophilin D, which regulates the swelling of mitochondria in response to cellular injury. Researches decided to test the drug in mice engineered to carry MD after earlier laboratory tests showed deleting a gene that encodes cycolphilin D reduced swelling and reversed or prevented the diseases muscle-damaging characteristics. The mice were engineered as models of Duchenne muscular dystrophy and forms caused by a deficiency of two structural proteins, delta-sarcoglycan and laminin alpha2.

Similar to deleting the gene encoding cyclophilin D, we found that treatment with Debio-025 reduced mitochondrial swelling and necrotic manifestations in mice with muscular dystrophy. This is why we believe inhibiting cyclophilin D could be a new treatment strategy, said Jeff Molkentin, Ph.D., corresponding author of the study and a researcher in the Division of Molecular Cardiovascular Biology at Cincinnati Childrens. Debio-025 has already passed Phase II clinical trials in Europe and is considered safe in people, so we want to explore the possibility of conducting clinical trials in patients with Duchenne MD.

During the onset of muscular dystrophy, the loss of certain proteins critical to muscle function such as dystrophin can lead to contraction-related micro-tears in muscle fibers and an influx of calcium around muscle tissue. When this happens, cyclophilin D is instructed to make the membranes of mitochondria more permeable. This causes mitochondria t
'/>"/>

Contact: Nick Miller
513-803-6035
Cincinnati Children's Hospital Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Enrollment completed in 2 pivotal phase III studies of the investigational cancer drug vandetanib
2. New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets
3. UCB Announces Positive Results From Phase II Clinical Trial of Investigational Anti-Epilepsy Drug Brivaracetam
4. SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor
5. MetaCure(TM) Launches Investigational Study of Gastric Stimulator for Patients With Type 2 Diabetes Who are Overweight
6. Abbotts Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study
7. Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
8. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
9. Supratek Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SP1049C for the treatment of metastatic adenocarcinoma of the upper gastrointestinal tract
10. Accentia announces investigational new drug application for Revimmune for refractory MS
11. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Forbes Living TV and featured ... that Ashley Lombardo and friend Candy Sherman are the ... Lombardo entered friend Candy Sherman to receive a generous ... her friend is courageously battling lung cancer and raising ... medical bills piling up and the constant struggle to ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 A ... was announced today which safely detects and identifies ... frequency radio waves. Developed by RHT SpectraSafe, the ... hosts broad applications in other areas including medical, ... security. , Using high frequency radio waves that ...
(Date:11/22/2014)... Wright & Schulte LLC reports that six ... been scheduled between October 2016 and April 2017 in ... District Judge Matthew F. Kennelly, who is overseeing the ... on November 6, 2014 that outlined the trial schedule ... and other activities in preparation for the bellwether jury ...
(Date:11/22/2014)... News) -- Many young people consider hookahs a hip ... finds fumes from the water pipes contain the toxin ... risk for leukemia in prior research, according to a ... Cancer Epidemiology, Biomarkers & Prevention . "In contrast ... a safe alternative to smoking other forms of tobacco," ...
(Date:11/22/2014)... widely used heart drug digoxin is associated with increased ... the heart rhythm disorder atrial fibrillation but no evidence ... fibrillation is a common form of irregular heartbeat that ... stroke among older Americans. Digoxin has been used for ... the authors of the new study said, and many ...
Breaking Medicine News(10 mins):Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:RHT SpectraSafe announces a Radical New Airport Security Technology that Is More Effective, Less Invasive 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4Health News:Hookahs Deliver Toxic Benzene in Every Puff, Study Shows 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 3
... a link between air pollution and heart attacks. ... and Haemostasis looks specifically at airborne particulate matter ... coal and also from forest fires, reports science ... and long-term exposure to these particulates is associated ...
... already a huge health problem in Asia that is getting ... years (by 2050), one out of every two fractures in ... figures projected above, it would be sensible for men and ... of their lifestyle. ,Osteoporosis, in which the bones ...
... a study in the September issue of Archives of ... for poor health and mental conditions//. ,Besides basic ... and understand numerical information such as that on prescription ... information such as appointment slips, to be able to ...
... face more than twice the risk of developing breast ... Netherlands examined the relation between handedness// and incidence of ... born between 1932 and 1941, reports science portal EurekAlert. ... such as social and economic status, smoking habits, family ...
... presenting a paper at the 109th Annual Meeting & ... held September 25-28, 2005 on the impact of age ... adult patients with inflammatory paranasal sinus disease at a ... disease is used to encompass CRS, CRS with polyposis, ...
... in the plant kingdom among pulses. Besides providing the body ... to have numerous other health benefits//. It is nicknamed as ... of diabetes, and improve overall health. ,Sometime back ... the Post menopausal period but now men have a reason ...
Cached Medicine News:Health News:Beauty Queens Urge On The Importance Of Maintaining Bone Integrity 2Health News:Age Can Changes Symptoms Of Sinusitis 2
(Date:11/21/2014)... 2014 Depomed, Inc. (NASDAQ: DEPO ) today ... th Annual Healthcare Conference in New York City ... is scheduled for 8:00 am EST (5:00 am PST) on Tuesday ... can be accessed via the Investor Relations page of the Depomed ... be archived for 30 days on the company,s website. ...
(Date:11/21/2014)... Nov. 20, 2014   Wellcentive , the ... for healthcare organizations, announced today being named one ... Intel Innovation Award .  Sponsored by Intel, the ... its fourth year, recognizes companies developing leading-edge technology ... delivery processes. Wellcentive,s Mason ...
(Date:11/18/2014)... LAWRENCE, Mass. , Nov. 18, 2014 /PRNewswire/ ... NXTM ), a leading manufacturer of innovative ... its new  Streamline® Express dialyzer for the ... blood tubing set, which is designed to reduce ... and to reduce the number of touch point ...
Breaking Medicine Technology:Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: